Predicting Biowarfare Agents Takes on Priority

The recent targeting of individuals and groups with the anthrax bacterium (Bacillus anthracis) has heightened the concern of the global community to bioterrorism. Unfortunately, the particular anthrax threat, and the responses discussed publicly, represent the tip of the iceberg. The anthrax bacterium cannot be transmitted through casual contact and is susceptible to antibiotics. In general, methods for anthrax prevention, detection, and treatment exist. Of far greater concern are readily transm

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Although only a limited number of viruses are considered suitable as biowarfare agents, a greater number might be made suitable through genetic engineering or other modifications. Those viral agents that have not been recognized previously as credible biowarfare agents pose a special threat, because their use would contain the element of surprise. For such agents, there would be no vaccines for prevention, no detection, and perhaps no therapies, and the potential destructive consequences would be far greater than those of the anthrax bacterium.

A recently published study,1 that used a text-mining variant known as literature-based discovery,2,3 identified viruses that could be considered as potential candidates for biowarfare agents. Generically, the study examined publicly available knowledge on different facets of biowarfare agents found in non-overlapping, highly specialized literatures and integrated these disparate literatures to identify viruses that had high potential as candidate biowarfare agents.

Specifically, the study postulated that biowarfare agents ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Ronald Kostoff

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours